Sign in and upgrade to a paid plan to export financials as CSV.
Sign in and upgrade to a paid plan to export financials as CSV.
Sign in and upgrade to a paid plan to export financials as CSV.
Sign in and upgrade to a paid plan to export financials as CSV.
Sign in and upgrade to a paid plan to export financials as CSV.

Panacea Biotec Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: PANACEABIO BSE: 531349

About Panacea Biotec Limited

Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products.

Source: Wikipedia

Key facts

BSE symbol531349
NSE symbolPANACEABIO
ISININE922B01023
CINL33117PB1984PLC022350
Listing date17 Apr 1996
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorR & D Company Secretaries (Debabrata Deb Nath)
Registered officeAmbala-Chandigarh Highway, Lalru - 140501, Punjab
Registrar & transfer agentSKYLINE FINANCIAL SERVICES PVT. LTD. D-153A, Ist Floor, Okhla Industrial Area, Phase-I, New Delhi - 110020

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 21
Total income (before exceptional items)431†326†385†—364†
Net profit-30-154-88—

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Ankesh JainExecutive DirectorJune 30, 2026
Harshet JainExecutive DirectorJune 30, 2026
Sandeep JainExecutive DirectorJune 30, 2026
Sanjay TrehanExecutive DirectorJune 30, 2026
Ambika SharmaIndependent DirectorJune 30, 2026
Krishan Kumar JalanIndependent DirectorJune 30, 2026
Rajender Pal SinghIndependent DirectorJune 30, 2026
Rajesh JainIndependent DirectorJune 30, 2026
Venkatesh SarvasiddhiIndependent DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.